KASH PETER M 4

4 · JAVELIN PHARMACEUTICALS, INC · Filed Dec 12, 2006

Form 4

Period: 2006-12-08

Director

Transactions

Other
Stock Options
2006-12-08$4.05/sh−26,575$107,629→ 252,835 total
Exercise: $4.05→ Common Stock (0 underlying)
Other
Stock Options
2006-12-08$1.96/sh+30,552$59,882→ 169,410 total
Exercise: $1.96→ Common Stock (30,552 underlying)
Other
Stock Options
2006-12-08$3.87/sh+87,116$337,139→ 87,116 total
Exercise: $3.87→ Common Stock (87,116 underlying)
Other
Stock Options
2006-12-08$2.70/sh+35,000$94,500→ 204,410 total
Exercise: $2.70→ Common Stock (35,000 underlying)
Other
Stock Options
2006-12-08$5.36/sh+51,742$277,337→ 138,858 total
Exercise: $5.36→ Common Stock (51,742 underlying)
Other
Stock Options
2006-12-08$4.05/sh+48,425$196,121→ 252,835 total
Exercise: $4.05→ Common Stock (48,425 underlying)

Footnotes (2)

[F1]Upon the resignation of Peter M. Kash as a Director of Javelin Pharmaceuticals, Inc., stock options previously granted to Mr. Kash under the 2005 Omnibus Stock Incentive Plan for an aggregate of 252,835 shares of Common Stock either were or became fully vested and exercisable in whole or in part for a period of 18 months (June 8, 2007) from the date of resignation.
[F2]The balance of options awarded to Mr. Kash for 26,575 shares of Common Stock were terminated upon such resignation.

Documents

1 file